Front-Runners in COVID-19 Antibody Drug Race

Published on October 14, 2021

While Pfizer, BioNTech and Merck are three of the biggest names in the COVID-19 vaccination race, AstraZeneca, Eli Lilly, Regeneron and GlaxoSmithKline are among the biggest players giving them a run for their money via COVID-19 antibody drugs.

Read Full Article (External Site)